Already Registered? Log In Now Not Registered?
Complete this form to enter the webcast. Already Registered?

(* indicates required field)

Complete this form to enter the webcast.
(* indicates required field)



*Denotes required.


Accelerating Biopharma Development and Manufacturing through CDMOs and CGT

Thu, Jul 20, 2023 11:00 AM EDT{LOCAL_TZ}

Event Overview

The biopharmaceutical industry has seen a lot of change in recent years, between new collaborations with supplier and contract development and manufacturing organizations (CDMOs) and accelerated drug delivery times. According to recent research, biopharmaceutical figures are already using digital and analytics for their benefit, with an increase of up to 40% in plant capacity, 20% in lead time, and 15% reduction in conversion costs (1).

With more growth comes more responsibilities, and processes like cell and gene therapy are on the forefront for the latest strategies to overcome the challenges in the manufacturing space.
In this Drug Digest video, Anil Kane, Global Head of Technical and Scientific Affairs, Pharma Services at Thermo Fisher Scientific, and Jason C. Foster, CEO and executive director at Ori Biotech, will provide expert insights into what happens in the manufacturing space from a CDMO and a cell/gene therapy perspective.Key Learning Objectives
  • The ability to identify the benefits of biopharma companies partnering with a CDMO 
  • The ability to learn about different kinds of cell and gene therapies and how to overcome the barriers in the continuous manufacturing space
  • Problem solving: ability to develop a plan for concepts, such as scalability and being more cost efficient, with new products and techniques
  • Awareness: ability to successfully pinpoint new approaches to medicine and how to respond as a biopharma company
Who Should Attend
  • Outsourcing/procurement professionals
  • CDMOs
  • Bio/pharma developers

Featured Speaker

Anil Kane
Anil Kane
Global Head of Technical and Scientific Affairs
Pharma Services at Thermo Fisher Scientific

For any technical questions please contact Jorge de la Bandera: JdelaBandera@mjhlifesciences.com